Ethics Approval

The institutional Ethics Committee of the Fundación Cardiovascular de Colombia approved the EMPA-Chagas study (CEI-2023–05269).

Consent to Participate

All patients provided their written informed consent for participation.

Consent for Publication

All authors agree to the publication of the manuscript in its present form.

Competing Interests

SAGO, LZR, and LEE received funding from Boehringer Ingelheim S.A. for the development of the EMPA-Chagas Study.